Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Oncology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Melanoma Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction Hematology, May 24, 2013 Clinical Article
2 Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey Hematology, May 24, 2013 Clinical Article
3 Primary research on unrelated double umbilical cord blood transplantation and implantation kinetics Hematology, May 24, 2013 Clinical Article
4 Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD working group of the Japan Society for Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation, May 24, 2013 Clinical Article
5 Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR Bone Marrow Transplantation, May 23, 2013 Clinical Article
6 IL-10 promoter polymorphism associated with decreased risk of aGvHD after stem cell transplantation: a meta-analysis International Journal of Hematology, May 23, 2013 Clinical Article
7 Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia Leukemia and Lymphoma, May 23, 2013 Review Article
8 BAALC and WT1 expression from diagnosis to hematopoietic stem cell transplantation: Consecutive monitoring in adult patients with core-binding factor-positive AML European Journal of Haematology, May 22, 2013 Clinical Article
9 Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction Hematology, May 22, 2013 Clinical Article
10 Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT Bone Marrow Transplantation, May 22, 2013 Clinical Article
11 Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT Bone Marrow Transplantation, May 22, 2013 Clinical Article
12 Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Bone Marrow Transplantation, May 22, 2013 Clinical Article
13 Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy Autoimmunity Reviews, May 21, 2013 Review Article
14 Mortality Rates of Human Metapneumovirus and Respiratory Syncytial Virus Lower Respiratory Tract Infections in Hematopoietic Cell Transplant Recipients Biology of Blood and Marrow Transplantation, May 21, 2013 Clinical Article
15 Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3-CD19 depletion Hematology, May 17, 2013 Clinical Article
16 Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey Hematology, May 16, 2013 Clinical Article
17 Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants European Journal of Clinical Pharmacology, May 15, 2013 Clinical Article
18 BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation, May 15, 2013 Clinical Article
19 Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography Bone Marrow Transplantation, May 15, 2013 Clinical Article
20 Late mortality after hematopoietic SCT for a childhood malignancy Bone Marrow Transplantation, May 15, 2013 Clinical Article
As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.
Read the article summaryAs reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.
Read the article summaryAs reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.
Read the article summaryIndexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close